KLP Kapitalforvaltning’s Dr. Reddy's Laboratories RDY Stock Holding History

KLP Kapitalforvaltning’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Hold	19,000	–	–	﹤0.01%	1767
2026 Q1	$263K	Hold	19,000	–	–	﹤0.01%	1711
2025 Q4	$267K	Hold	19,000	–	–	﹤0.01%	1729
2025 Q3	$266K	Hold	19,000	–	–	﹤0.01%	1704
2025 Q2	$286K	Buy	19,000 +13,000	+217%	+$186K	﹤0.01%	1618
2025 Q1	$79.1K	Hold	6,000	–	–	﹤0.01%	2100
2024 Q4	$94.7K	Buy	+6,000	New	+$90.1K	﹤0.01%	2106

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

KLP Kapitalforvaltning's RDY Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 19,000 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

KLP Kapitalforvaltning first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $286K in Q2 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

KLP Kapitalforvaltning held 19,000 shares of Dr. Reddy's Laboratories worth $275K as of Q2 2026.
KLP Kapitalforvaltning left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1767 holding.
KLP Kapitalforvaltning first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Dr. Reddy's Laboratories position peaked at $286K in Q2 2025.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.